Improving accuracy in genome editing
A team of scientists, led by Harvard University's David Liu, has developed an engineered form of the genome-editing protein Cas9 that can be turned on with a small drug-like molecule. This approach achieves up to 25-fold higher specificity in genome editing than the standard form of Cas9.